0
How infections spread: the case for varied and dynamic inputs
Understanding infectious disease spread is problematic, given the randomness of most outbreaks. Yet attempting to predict the transmission wave is…
Browsing: Research > Clinical
0
A COVID-19 vaccine for people with B-cell deficiency
Those with B-cell deficiencies are still vulnerable following current COVID-19 vaccinations; however, researchers have created a new vaccine that targets…
0
Eradicating polio – an interview with Erin Stuckey
In celebration of International Women’s Day this year, we spoke to Erin Stuckey (Bill & Melinda Gates Foundation; WA, USA) about…
1
DNA-encoded immunogens: the next step forward in HIV vaccine research
Researchers demonstrate the value of nucleic acid technology in encoding immunogens capable of eliciting tier-2 neutralizing antibodies against HIV in the race to develop…
0
Global disparities in access to COVID-19 vaccines – an interview with Boghuma Kabisen Titanji
In celebration of Black History Month this year, we spoke to Boghuma Kabisen Titanji (Emory University; GA, USA) about her experience…
0
eBook: The top microbiology and virology articles of 2021
The microbiology and virology fields have been dominated by COVID-19 research again this year; however, important research is still being…
0
Getting to the heart of COVID-19 mRNA vaccines
For a very small portion of people, a rare form of heart inflammation called carditis can occur after COVID-19 vaccination. But what’s the…
0
Benefit of breastmilk: COVID-19 antibodies pass from vaccinated mothers to infants
Study detects neutralizing antibodies against SARS-CoV-2 in stool samples of infants breastfed by vaccinated mothers with the potential to provide passive immunity against the…
0
Experimental enzyme shows promise as a prophylaxis to anthrax spores
Sometimes in experimental biology the very factor that is part of the disease-causing mechanism can also be the factor that…
0
Hope for HIV: mRNA vaccine displays encouraging results in animal studies
A new mRNA HIV vaccine technology encodes key proteins to form virus-like particles (VLPs) that induce neutralizing antibodies safely and effectively in animal studies with minimal side effects. Researchers from…